Patents by Inventor Garth Cumberlidge

Garth Cumberlidge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Beta-turn peptidomimetic cyclic compounds for treating dry eye
    Patent number: 9707267
    Abstract: The present invention relates to methods of treating dry eye using ?-turn peptidomimetic cyclic compounds or derivatives thereof. The ?-turn peptidomimetic cyclic compounds can be used alone, in combination and/or in conjunction with one or more other compounds, molecules or drugs that treat dry eye.
    Type: Grant
    Filed: September 18, 2015
    Date of Patent: July 18, 2017
    Assignee: Mimetogen Pharmaceuticals, Inc.
    Inventors: Garth Cumberlidge, Karen Meerovitch, Teresa Lama, Horacio Uri Saragovi
  • Beta-turn peptidomimetic cyclic compounds for treating dry eye
    Patent number: 9156882
    Abstract: The present invention relates to methods of treating dry eye using ?-turn peptidomimetic cyclic compounds or derivatives thereof. The ?-turn peptidomimetic cyclic compounds can be used alone, in combination and/or in conjunction with one or more other compounds, molecules or drugs that treat dry eye.
    Type: Grant
    Filed: May 29, 2014
    Date of Patent: October 13, 2015
    Assignee: MIMETOGEN PHARMACEUTICALS, INC.
    Inventors: Garth Cumberlidge, Karen Meerovitch, Teresa Lama
  • ?-turn peptidomimetic cyclic compounds for treating dry eye
    Patent number: 8748391
    Abstract: The present invention relates to methods of treating dry eye using ?-turn peptidomimetic cyclic compounds or derivatives thereof. The ?-turn peptidomimetic cyclic compounds can be used alone, in combination and/or in conjunction with one or more other compounds, molecules or drugs that treat dry eye.
    Type: Grant
    Filed: August 31, 2012
    Date of Patent: June 10, 2014
    Assignee: Mimetogen Pharmaceuticals Inc.
    Inventors: Garth Cumberlidge, Karen Meerovitch, Teresa Lama
  • Methods of treating retinitis pigmentosa
    Patent number: 8653036
    Abstract: The present invention relates to methods of treating retinitis pigmentosa using ?-turn peptidomimetic cyclic compounds or derivatives thereof. The ?-turn peptidomimetic cyclic compounds can be used alone, in combination and/or in conjunction with one or more other compounds, molecules or drugs useful in treating retinitis pigmentosa.
    Type: Grant
    Filed: February 26, 2010
    Date of Patent: February 18, 2014
    Assignee: Mimetogen Pharmaceuticals Inc.
    Inventors: Garth Cumberlidge, Horacio U. Saragovi, Karen Meerovitch
  • Beta-turn peptidomimetic cyclic compounds for treating dry eye
    Patent number: 8293713
    Abstract: The present invention relates to methods of treating dry eye using ?-turn peptidomimetic cyclic compounds or derivatives thereof. The ?-turn peptidomimetic cyclic compounds can be used alone, in combination and/or in conjunction with one or more other compounds, molecules or drugs that treat dry eye.
    Type: Grant
    Filed: April 3, 2009
    Date of Patent: October 23, 2012
    Assignee: Mimetogen Pharmaceuticals, Inc.
    Inventors: Garth Cumberlidge, Karen Meerovitch, Teresa Lama
  • METHODS OF TREATING RETINITIS PIGMENTOSA
    Publication number: 20120165271
    Abstract: The present invention relates to methods of treating retinitis pigmentosa using ?-turn peptidomimetic cyclic compounds or derivatives thereof. The ?-turn peptidomimetic cyclic compounds can be used alone, in combination and/or in conjunction with one or more other compounds, molecules or drugs useful in treating retinitis pigmentosa.
    Type: Application
    Filed: February 26, 2010
    Publication date: June 28, 2012
    Inventors: Garth Cumberlidge, Horacio U. Saragovi, Karen Meerovitch
  • Beta-Turn Peptidomimetic Cyclic Compounds for Treating Dry Eye
    Publication number: 20110105410
    Abstract: The present invention relates to methods of treating dry eye using ?-turn peptidomimetic cyclic compounds or derivatives thereof. The ?-turn peptidomimetic cyclic compounds can be used alone, in combination and/or in conjunction with one or more other compounds, molecules or drugs that treat dry eye.
    Type: Application
    Filed: April 3, 2009
    Publication date: May 5, 2011
    Inventors: Garth Cumberlidge, Karen Meerovitch, Teresa Lama